메뉴 건너뛰기




Volumn 27, Issue 3, 2012, Pages 142-150

Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment

Author keywords

adjunctive treatment; generalized anxiety disorder; pregabalin

Indexed keywords

PLACEBO; PREGABALIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

EID: 84859268366     PISSN: 02681315     EISSN: 14735857     Source Type: Journal    
DOI: 10.1097/YIC.0b013e328350b133     Document Type: Article
Times cited : (54)

References (43)
  • 2
    • 27544471383 scopus 로고    scopus 로고
    • Adjunctive risperidone in generalized anxiety disorder: A double-blind, placebo-controlled study
    • Brawman-Mintzer O, Knapp RG, Nieterts PJ (2005). Adjunctive risperidone in generalized anxiety disorder: a double-blind, placebo-controlled study. J Clin Psychiatry 66:1321-1325. (Pubitemid 41546513)
    • (2005) Journal of Clinical Psychiatry , vol.66 , Issue.10 , pp. 1321-1325
    • Brawman-Mintzer, O.1    Knapp, R.G.2    Nietert, P.J.3
  • 4
    • 19644370282 scopus 로고    scopus 로고
    • Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: A 12-year prospective study
    • DOI 10.1176/appi.ajp.162.6.1179
    • Bruce SE, Yonkers KA, Otto MW, Eisen JL, Weisberg RB, Pagano M, et al. (2005). Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry 162:1179-1187. (Pubitemid 40770702)
    • (2005) American Journal of Psychiatry , vol.162 , Issue.6 , pp. 1179-1187
    • Bruce, S.E.1    Yonkers, K.A.2    Otto, M.W.3    Eisen, J.L.4    Weisberg, R.B.5    Pagano, M.6    Shea, M.T.7    Keller, M.B.8
  • 5
    • 0030670430 scopus 로고    scopus 로고
    • Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data
    • DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0. CO;2-E
    • Cnaan A, Laird NM, Slasor P (1997). Using the general linear model to analyse unbalanced repeated measures and longitudinal data. Stat Med 16: 2349-2380. (Pubitemid 27458250)
    • (1997) Statistics in Medicine , vol.16 , Issue.20 , pp. 2349-2380
    • Cnaan, A.1    Laird, N.M.2    Slasor, P.3
  • 6
    • 0035884250 scopus 로고    scopus 로고
    • Sample size recalculation using conditional power
    • DOI 10.1002/sim.734
    • Denne JS (2001). Sample size recalculation using conditional power. Stat Med 20:2645-2660. (Pubitemid 32834374)
    • (2001) Statistics in Medicine , vol.20 , Issue.17-18 , pp. 2645-2660
    • Denne, J.S.1
  • 7
    • 0024887538 scopus 로고
    • Testing for random dropouts in repeated measurement data
    • Diggle PJ (1989). Testing for random dropouts in repeated measurement data. Biometrics 45:1255-1258. (Pubitemid 20085467)
    • (1989) Biometrics , vol.45 , Issue.4 , pp. 1255-1258
    • Diggle, P.J.1
  • 10
    • 84859265693 scopus 로고    scopus 로고
    • U.S. Dept of Health, Education, and Welfare, Public Health Service National Institute of Mental Health Psychopharmacology Research Branch, Division of Extramural Programs;
    • Rockville, MD: U.S. Dept of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Programs; pp. 276-338.
    • Alcohol, Drug Abuse, and Mental Health Administration , pp. 276-338
    • Rockville, M.D.1
  • 11
    • 51549099524 scopus 로고
    • The assessment of anxiety states by rating
    • Hamilton M (1959). The assessment of anxiety states by rating. Br J Med Psychol 32:50-55.
    • (1959) Br J Med Psychol , vol.32 , pp. 50-55
    • Hamilton, M.1
  • 13
    • 0002105479 scopus 로고    scopus 로고
    • Application of random-effects pattern-mixture models for missing data in longitudinal studies
    • Hedeker D, Gibbons RD (1997). Applications of random-effects pattern mixture models for missing data in longitudinal studies. Psychol Methods 2:64-78. (Pubitemid 127453671)
    • (1997) Psychological Methods , vol.2 , Issue.1 , pp. 64-78
    • Hedeker, D.1    Gibbons, R.D.2
  • 14
    • 35648988598 scopus 로고    scopus 로고
    • An effect-size analysis of pharmacologic treatments for generalized anxiety disorder
    • DOI 10.1177/0269881107076996
    • Hidalgo RB, Tupler LA, Davidson JR (2007). An effect-size analysis of pharmacologic treatments for generalized anxiety disorder. J Psychopharmacol 21:864-872. (Pubitemid 350029180)
    • (2007) Journal of Psychopharmacology , vol.21 , Issue.8 , pp. 864-872
    • Hidalgo, R.B.1    Tupler, L.A.2    Davidson, J.R.T.3
  • 15
    • 38949154090 scopus 로고    scopus 로고
    • Human and economic burden of generalized anxiety disorder
    • DOI 10.1002/da.20257
    • Hoffman DL, Dukes EM,Wittchen H-U (2008). Human and economic burden of generalized anxiety disorder. Depress Anxiety 25:72-90. (Pubitemid 351213928)
    • (2008) Depression and Anxiety , vol.25 , Issue.1 , pp. 72-90
    • Hoffman, D.L.1    Dukes, E.M.2    Wittchen, H.-U.3
  • 16
    • 46949106005 scopus 로고    scopus 로고
    • Aripiprazole as augmentation treatment of refractory generalized anxiety disorder and panic disorder
    • Hoge EA,Worthington JJ 3rd, Kaufman RE, Delong HR, Pollack MH, Simon NM (2008). Aripiprazole as augmentation treatment of refractory generalized anxiety disorder and panic disorder. CNS Spect 13:522-527. (Pubitemid 351960777)
    • (2008) CNS Spectrums , vol.13 , Issue.6 , pp. 522-527
    • Hoge, E.A.1    Worthington III, J.J.2    Kaufman, R.E.3    Delong, H.R.4    Pollack, M.H.5    Simon, N.M.6
  • 17
    • 53149142767 scopus 로고    scopus 로고
    • Quetiapine as an adjunctive pharmacotherapy for the treatment of nonremitting generalized anxiety disorder: A flexible-dose, open-label pilot trial
    • Katzman MA, Vermani M, Jacobs L, Marcus M, Kong B, Lessard S, et al. (2008). Quetiapine as an adjunctive pharmacotherapy for the treatment of nonremitting generalized anxiety disorder: a flexible-dose, open-label pilot trial. J Anxiety Disord 22:1480-1486.
    • (2008) J Anxiety Disord , vol.22 , pp. 1480-1486
    • Katzman, M.A.1    Vermani, M.2    Jacobs, L.3    Marcus, M.4    Kong, B.5    Lessard, S.6
  • 18
    • 0032697699 scopus 로고    scopus 로고
    • Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys
    • Kessler RC, DuPont RL, Berglund P, Wittchen H-U (1999). Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys. Am J Psychiatry 156:1915-1923.
    • (1999) Am J Psychiatry , vol.156 , pp. 1915-1923
    • Kessler, R.C.1    Dupont, R.L.2    Berglund, P.3    Wittchen, H.-U.4
  • 19
    • 20344385026 scopus 로고    scopus 로고
    • Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication
    • DOI 10.1001/archpsyc.62.6.593
    • Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62:593-602. (Pubitemid 40973434)
    • (2005) Archives of General Psychiatry , vol.62 , Issue.6 , pp. 593-602
    • Kessler, R.C.1    Berglund, P.2    Demler, O.3    Jin, R.4    Merikangas, K.R.5    Walters, E.E.6
  • 20
    • 70449529019 scopus 로고
    • Discrete sequential boundaries for clinical trials
    • Lan KKG, DeMets DL (1983). Discrete sequential boundaries for clinical trials. Biometrika 70:659-663.
    • (1983) Biometrika , vol.70 , pp. 659-663
    • Lan, K.K.G.1    Demets, D.L.2
  • 21
    • 0023677293 scopus 로고
    • The B-value: A tool for monitoring data
    • Lan KKG, Wittes J (1988). The B-value: a tool for monitoring data. Biometrics 44:579-585.
    • (1988) Biometrics , vol.44 , pp. 579-585
    • Lan, K.K.G.1    Wittes, J.2
  • 22
    • 0037273401 scopus 로고    scopus 로고
    • Assessing response profiles from incomplete longitudinal clinical trial data under regulatory considerations
    • DOI 10.1081/BIP-120019265
    • Mallinckrodt CH, Clark SW, Carroll RJ, Molenbergh G (2003). Assessing response profiles from incomplete longitudinal clinical trial data under regulatory considerations. J Biopharm Stat 13:179-190. (Pubitemid 36523156)
    • (2003) Journal of Biopharmaceutical Statistics , vol.13 , Issue.2 , pp. 179-190
    • Mallinckrodt, C.H.1    Clark, W.S.2    Carroll, R.J.3    Molenberghs, G.4
  • 23
    • 0003541554 scopus 로고
    • designed experiments. New York: Van Nostrand Reinhold
    • Milliken GA, Johnson DE (1986). Analysis of messy data, volume 1: designed experiments. New York: Van Nostrand Reinhold.
    • (1986) Analysis of Messy Data , vol.1
    • Milliken, G.A.1    De, J.2
  • 24
    • 15444365574 scopus 로고    scopus 로고
    • A meta-analytic review of the efficacy of drug treatment in generalized anxiety disorder
    • DOI 10.1097/01.jcp.0000155821.74832.f9
    • Mitte K, Noack P, Steil R, Hautzinger M (2005). A meta-analytic review of the efficacy of drug treatment in generalized anxiety disorder. J Clin Psychopharmacol 25:141-150. (Pubitemid 40395092)
    • (2005) Journal of Clinical Psychopharmacology , vol.25 , Issue.2 , pp. 141-150
    • Mitte, K.1    Noack, P.2    Steil, R.3    Hautzinger, M.4
  • 25
    • 55949104118 scopus 로고    scopus 로고
    • Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder
    • Montgomery S, Chatamra K, Pauer L,Whalen E, Baldinetti F (2008). Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder. Br J Psychiatry 193:389-394.
    • (2008) Br J Psychiatry , vol.193 , pp. 389-394
    • Montgomery, S.1    Chatamra, K.2    Pauer, L.3    Whalen, E.4    Baldinetti, F.5
  • 26
    • 33750125418 scopus 로고    scopus 로고
    • Pregabalin for the treatment of generalised anxiety disorder
    • Montgomery SA (2006). Pregabalin for the treatment of generalised anxiety disorder. Expert Opin Pharmacother 7:2139-2154.
    • (2006) Expert Opin Pharmacother , vol.7 , pp. 2139-2154
    • Montgomery, S.A.1
  • 27
    • 80051549520 scopus 로고    scopus 로고
    • Pharmacotherapy update: Pregabalin in the treatment of generalized anxiety disorder
    • Montgomery SA, Kasper S (2010). Pharmacotherapy update: pregabalin in the treatment of generalized anxiety disorder. Clin Med Insights Ther 2:189-202.
    • (2010) Clin Med Insights Ther , vol.2 , pp. 189-202
    • Montgomery, S.A.1    Kasper, S.2
  • 28
    • 49149131149 scopus 로고    scopus 로고
    • Development and evaluation of the Daily Assessment of Symptoms-Anxiety (DAS-A) scale to evaluate onset of symptom relief in patients with generalized anxiety disorder
    • Morlock RJ, Williams VS, Cappelleri JC, Harness J, Fehnel SE, Endicott J, et al. (2008). Development and evaluation of the Daily Assessment of Symptoms-Anxiety (DAS-A) scale to evaluate onset of symptom relief in patients with generalized anxiety disorder. J Psychiatr Res 42:1024-1036.
    • (2008) J Psychiatr Res , vol.42 , pp. 1024-1036
    • Morlock, R.J.1    Williams, V.S.2    Cappelleri, J.C.3    Harness, J.4    Fehnel, S.E.5    Endicott, J.6
  • 29
    • 0018687930 scopus 로고
    • A multiple testing procedure for clinical trials
    • DOI 10.2307/2530245
    • O'Brien PC, Fleming TR (1979). A multiple testing procedure for clinical trials. Biometrics 35:549-556. (Pubitemid 10242750)
    • (1979) Biometrics , vol.35 , Issue.3 , pp. 549-556
    • O'Brien, P.C.1    Fleming, T.R.2
  • 30
    • 32144450616 scopus 로고    scopus 로고
    • Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: A placebo controlled study
    • DOI 10.1016/j.biopsych.2005.07.005, PII S0006322305008528
    • Pollack MH, Simon NM, Zalta AK,Worthington JJ, Hoge EA, Mick E, et al. (2006). Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled study. Biol Psychiatry 59:211-215. (Pubitemid 43208966)
    • (2006) Biological Psychiatry , vol.59 , Issue.3 , pp. 211-215
    • Pollack, M.H.1    Simon, N.M.2    Zalta, A.K.3    Worthington, J.J.4    Hoge, E.A.5    Mick, E.6    Kinrys, G.7    Oppenheimer, J.8
  • 31
    • 0029589385 scopus 로고
    • Designed extension of studies based on conditional power
    • DOI 10.2307/2533262
    • Proschan MA, Hunsberger SA (1995). Designed extension of studies based on conditional power. Biometrics 51:1315-1324. (Pubitemid 26030176)
    • (1995) Biometrics , vol.51 , Issue.4 , pp. 1315-1324
    • Proschan, M.A.1    Hunsberger, S.A.2
  • 32
    • 0026325551 scopus 로고
    • Testing for random dropouts in repeated measurement data, reader reaction
    • Ridout MS (1991). Testing for random dropouts in repeated measurement data, reader reaction. Biometrics 47:1617-1621.
    • (1991) Biometrics , vol.47 , pp. 1617-1621
    • Ridout, M.S.1
  • 33
    • 5444232126 scopus 로고    scopus 로고
    • Primary care perspectives on generalized anxiety disorder
    • Roy-Byrne PP, Wagner A (2004). Primary care perspectives on generalized anxiety disorder. J Clin Psychiatry 65 (Suppl 13):20-26.
    • (2004) J Clin Psychiatry , vol.65 , Issue.13 SUPPL. , pp. 20-26
    • Roy-Byrne, P.P.1    Wagner, A.2
  • 37
    • 41849148995 scopus 로고    scopus 로고
    • Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: Preliminary findings
    • Simon NM, Connor KM, LeBeau RT, Hoge EA,Worthington JJ III, Zhang W, et al. (2008). Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings. Psychopharmacology 197:675-681.
    • (2008) Psychopharmacology , vol.197 , pp. 675-681
    • Simon, N.M.1    Connor, K.M.2    Lebeau, R.T.3    Hoge, E.A.4    Worthington Iii, J.J.5    Zhang, W.6
  • 38
    • 25444460399 scopus 로고    scopus 로고
    • Open-label pilot study of ziprasidone for refractory generalized anxiety disorder [2]
    • DOI 10.1097/01.jcp.0000177853.15910.de
    • Snyderman SH, Rynn MA, Rickels K (2005). Open-label pilot study of ziprasidone for refractory generalized anxiety disorder. J Clin Psychopharmacol 25:497-499. (Pubitemid 41368377)
    • (2005) Journal of Clinical Psychopharmacology , vol.25 , Issue.5 , pp. 497-499
    • Snydermae, S.H.1    Rynn, M.A.2    Rickels, K.3
  • 39
    • 33847286912 scopus 로고    scopus 로고
    • 2-delta) subunit as a target for antiepileptic drug discovery
    • DOI 10.1016/j.eplepsyres.2006.09.008, PII S0920121106003895
    • Taylor CP, Angelotti T, Fauman E (2007). Pharmacology and mechanism of action of pregabalin: the calcium channel a2-d (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res 73:137-150. (Pubitemid 46329329)
    • (2007) Epilepsy Research , vol.73 , Issue.2 , pp. 137-150
    • Taylor, C.P.1    Angelotti, T.2    Fauman, E.3
  • 40
    • 27744458830 scopus 로고    scopus 로고
    • Results of a naturalistic longitudinal study of benzodiazepine and SSRI use in the treatment of generalized anxiety disorder and social phobia
    • DOI 10.1002/da.20089
    • Vasile RG, Bruce SE, Goisman RM, Pagano M, Keller MB (2005). Results of a naturalistic longitudinal study of benzodiazepine and SSRI use in the treatment of generalized anxiety disorder and social phobia. Depress Anxiety 22:59-67. (Pubitemid 41598041)
    • (2005) Depression and Anxiety , vol.22 , Issue.2 , pp. 59-67
    • Vasile, R.G.1    Bruce, S.E.2    Goisman, R.M.3    Pagano, M.4    Keller, M.B.5
  • 43
    • 0026878098 scopus 로고
    • Benzodiazepines: Use, abuse, and consequences
    • Woods JH, Katz JL, Winger G (1992). Benzodiazepines: use, abuse, and consequences. Pharmacol Rev 44:151-347.
    • (1992) Pharmacol Rev , vol.44 , pp. 151-347
    • Woods, J.H.1    Katz, J.L.2    Winger, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.